NPPB and interstitial lung disease: Without the raw data from the REVEAL registry, we are unable to determine which of the shared parameters between our models and REVEAL may be “driving” the similar c-indices, but we postulate that the NT-proBNP may have an influence as this biomarker is strongly correlated with prognosis in both PAH and ILD.5, 16